Mark Alan Goldberg Insider Trading $GLYC GLYCOMIMETICS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Alan Goldberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Alan Goldberg. Mark Alan Goldberg is Director in IMMUNOGEN INC ($IMGN) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in GLYCOMIMETICS INC ($GLYC) and Director in aTYR PHARMA INC ($LIFE) and Director in Blueprint Medicines Corp ($BPMC) and Director in Audentes Therapeutics, Inc. ($BOLD).
Mark Alan Goldberg in GLYCOMIMETICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Alan Goldberg: Director
Holdings: 5,250 shares
Current Value: $32,865
Latest Transaction: May 27 2021
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark Alan Goldberg in GLYCOMIMETICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LIFE, BOLD, BPMC, GLYC, IDRA, IMGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 2.55 | 10,500 | 26,775 | 10,500 | |
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Grant | A | 0.00 | 5,250 | 0 | 5,250 | 0 to 5.3 K |
| May 27 2020 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 3.00 | 21,000 | 63,000 | 21,000 | |
| May 21 2019 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 12.39 | 21,000 | 260,190 | 21,000 | |
| May 21 2018 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 18.41 | 11,000 | 202,510 | 11,000 | |
| May 30 2017 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 13.89 | 11,000 | 152,790 | 11,000 | |
| May 19 2016 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 6.35 | 11,000 | 69,850 | 11,000 | |
| Mar 07 2016 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Buy | P | 4.77 | 10,397 | 49,630 | 11,497 | 1.1 K to 11.5 K (+945.18 %) |
| Aug 11 2015 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 7.50 | 11,000 | 82,500 | 11,000 |
Page: 1